Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
accredited labs 99%+ purity HPLC verified 3x TRIPLE AGONIST GLP-1, GIP, and glucagon receptors 24% BODY WEIGHT Reduction in Phase 2 trials (retatrutide) 50+ PUBLICATIONS Rapidly growing research base 2023 PHASE 2 DATA Presented at ADA conference 39AA SEQUENCE Modified triple-agonist peptide Free shipping on orders over $150 Quality guarantee 99%+ purity verified Secure checkout 256-bit SSL encryption Research GLP-3 R (CAS 2381089-83-2) is the research designation applied to the synthetic triple-receptor agonist peptide also catalogued as retatrutide / LY3437943
Glucose concentrations were also not affected by sitagliptin treatment
New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms
Huang J-Q, Wei F-K, Xu X-L, Ye S-X, Song J-W, Ding P-K, et al
Product highlights include: High-purity GHK-Cu peptide formulation Laboratory-grade quality standards Carefully sealed packaging for stability Suitable for cosmetic and peptide research applications Manufactured with consistency and precision in mind Researchers and peptide buyers often prioritize trusted sourcing and transparent quality standards when selecting peptide compounds
US$ 28.33
US$ 29.68
US$ 26.29
US$ 26.83
US$ 21.50
US$ 29.61
